The buyout market may be challenging but there are some attractive opportunities to transfer risk, and the case for longevity protection is strengthening, argues Gordon Fletcher
Register for a trial Please sign in to read the full content of this article. If you aren’t already a subscriber, you can register for a free one-month trial.